Integration of Clinical Trial Development in Hematology-Oncology Fellowship Training.

IF 5.3 2区 教育学 Q1 EDUCATION, SCIENTIFIC DISCIPLINES
Academic Medicine Pub Date : 2025-01-01 Epub Date: 2024-05-30 DOI:10.1097/ACM.0000000000005773
Christine Auberle, Ningying Wu, John F Dipersio, Saiama N Waqar, Lee Ratner
{"title":"Integration of Clinical Trial Development in Hematology-Oncology Fellowship Training.","authors":"Christine Auberle, Ningying Wu, John F Dipersio, Saiama N Waqar, Lee Ratner","doi":"10.1097/ACM.0000000000005773","DOIUrl":null,"url":null,"abstract":"<p><strong>Problem: </strong>Several barriers to physicians becoming clinical investigators exist, including inexperience, lack of available mentors, and inconsistent instructive approaches with varying degrees of participation during training. These barriers cause fewer hematology-oncology fellows to pursue academic careers. A consensus is needed on structuring education in clinical investigation paired with active participation in development of a clinical trial guided by a mentor with the goal of increasing fellow interest in clinical research and pursuit of careers in academic medicine.</p><p><strong>Approach: </strong>The clinical trial development (CTD) program was initiated at Washington University School of Medicine in St. Louis in 2002 as a hands-on learning experience for hematology and oncology fellows in the design, implementation, and publication of clinical trials. Each fellow was required to identify a mentor and propose at least 1 prospective investigator-initiated clinical trial.</p><p><strong>Outcomes: </strong>At the time of data abstraction in July 2023, 118 fellows had participated in the CTD program and initiated protocols in a variety of areas according to their interests. Fellows were included in data abstraction if their fellowship began in 2002 through 2021; the program is ongoing, and the most recent class will graduate in 2024. Disease types were evenly distributed between solid tumor oncology (60 [51%]) or classic and malignant hematology (58 [49%]). Ninety-three fellows (79%) obtained institutional review board approval, and 60 (65%) published their results. Among graduating fellows, 67 (66%) secured an academic faculty appointment. Fellows with institutional review board-approved projects had significantly higher odds of obtaining an academic faculty appointment (odds ratio, 4.96; 95% confidence interval, 1.54-15.98; P = .007).</p><p><strong>Next steps: </strong>Next steps will be to further evaluate the effect of the mentorship network on early career productivity of trainees that graduate and the feasibility of extending the program to another institution.</p>","PeriodicalId":50929,"journal":{"name":"Academic Medicine","volume":" ","pages":"38-41"},"PeriodicalIF":5.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Academic Medicine","FirstCategoryId":"95","ListUrlMain":"https://doi.org/10.1097/ACM.0000000000005773","RegionNum":2,"RegionCategory":"教育学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"EDUCATION, SCIENTIFIC DISCIPLINES","Score":null,"Total":0}
引用次数: 0

Abstract

Problem: Several barriers to physicians becoming clinical investigators exist, including inexperience, lack of available mentors, and inconsistent instructive approaches with varying degrees of participation during training. These barriers cause fewer hematology-oncology fellows to pursue academic careers. A consensus is needed on structuring education in clinical investigation paired with active participation in development of a clinical trial guided by a mentor with the goal of increasing fellow interest in clinical research and pursuit of careers in academic medicine.

Approach: The clinical trial development (CTD) program was initiated at Washington University School of Medicine in St. Louis in 2002 as a hands-on learning experience for hematology and oncology fellows in the design, implementation, and publication of clinical trials. Each fellow was required to identify a mentor and propose at least 1 prospective investigator-initiated clinical trial.

Outcomes: At the time of data abstraction in July 2023, 118 fellows had participated in the CTD program and initiated protocols in a variety of areas according to their interests. Fellows were included in data abstraction if their fellowship began in 2002 through 2021; the program is ongoing, and the most recent class will graduate in 2024. Disease types were evenly distributed between solid tumor oncology (60 [51%]) or classic and malignant hematology (58 [49%]). Ninety-three fellows (79%) obtained institutional review board approval, and 60 (65%) published their results. Among graduating fellows, 67 (66%) secured an academic faculty appointment. Fellows with institutional review board-approved projects had significantly higher odds of obtaining an academic faculty appointment (odds ratio, 4.96; 95% confidence interval, 1.54-15.98; P = .007).

Next steps: Next steps will be to further evaluate the effect of the mentorship network on early career productivity of trainees that graduate and the feasibility of extending the program to another institution.

将临床试验开发纳入血液肿瘤学研究员培训。
问题:医生成为临床研究人员存在一些障碍,包括缺乏经验、缺少导师以及在培训期间参与程度不同的指导方法不一致。这些障碍导致较少的血液肿瘤学研究员从事学术研究工作。我们需要就临床研究教育的结构达成共识,并在导师的指导下积极参与临床试验的开发,目的是提高研究人员对临床研究的兴趣,并追求学术医学的职业生涯:临床试验开发(CTD)项目于 2002 年在圣路易斯华盛顿大学医学院启动,作为血液学和肿瘤学研究员在临床试验的设计、实施和发布方面的实践学习经历。每位研究员都必须确定一名导师,并提出至少一项由研究者发起的前瞻性临床试验:在 2023 年 7 月进行数据摘要时,共有 118 名研究员参加了 CTD 计划,并根据自己的兴趣在不同领域启动了方案。从2002年开始到2021年的研究员都被纳入了数据摘要;该计划正在进行中,最近一届研究员将于2024年毕业。疾病类型平均分布在实体瘤肿瘤学(60 [51%])或经典和恶性血液学(58 [49%])之间。93名研究员(79%)获得了机构审查委员会的批准,60名研究员(65%)发表了研究结果。在毕业的研究员中,有 67 人(66%)获得了学术教职。项目获得机构评审委员会批准的研究员获得学术教职的几率明显更高(几率比,4.96;95% 置信区间,1.54,15.98;P = .007)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Academic Medicine
Academic Medicine 医学-卫生保健
CiteScore
7.80
自引率
9.50%
发文量
982
审稿时长
3-6 weeks
期刊介绍: Academic Medicine, the official peer-reviewed journal of the Association of American Medical Colleges, acts as an international forum for exchanging ideas, information, and strategies to address the significant challenges in academic medicine. The journal covers areas such as research, education, clinical care, community collaboration, and leadership, with a commitment to serving the public interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信